Skip to main content icon/video/no-internet

Although genomic information is not yet widely applied in the business world, rapidly growing knowledge about the workings of our genes has the potential to give businesses fuller information about the future, as well as the current, health of the individuals with whom they deal. People's genetic condition—acquired either through inheritance or mutation—affects whether they are disposed to manifest symptoms of various kinds of illnesses. Genomics already has shown that humans are less able to control what illnesses they will suffer from than advocates of healthy lifestyles and preventative care may hope.

Genetic testing could help make what is not controllable at least more predictable for businesses. For example, information from genetic testing could enable businesses to reduce risks arising from people susceptible to certain adverse health conditions being included in their employee or customer pools. Genetic testing, therefore, could offer useful information to businesses that are affected by the health of individuals with which they deal, and genetic testing may become more common as more, and more economical, tests become available.

Ethical Issues

That such information could be used to advance organizational interests at the expense of individuals raises several crucial ethical issues, however. For example, businesses could use people's genetic information to separate individuals who carry risks of ill health from employment or to defend against victims' claims for compensation by claiming that the harm is traceable to their genes. Conversely, individuals could use knowledge of their own genetic inheritance to gain advantage over an organization, for instance, by not revealing having inherited an allele associated with the early onset of a degenerative disease to an organization that relies on the individual's remaining well. These and similar possible uses raise concrete ethical questions are about who owns such genetic information and in what circumstances it may or must be revealed, or instead must be considered confidential. Prior to these, however, there are theoretical ethical questions centering on the degree to which individuals should bear social accountability for biological outcomes they cannot control, such as health risks resulting from their having certain configurations of genes.

We cannot be fully free to take advantage of one another's bad luck. For if we were, fear of falling prey to other people when luck deserts us could deter us from productive engagement with one another. So protective constraints that regulate our interactions with one another are basic to cultivating the cooperative climate on which commerce depends. Whether such protections should extend to protecting people against the medical and social consequences of inherited bad health is a matter of conscience as well as of moral, legal, and political debate. The proposition that risk should be distributed beyond the individuals whose health is made problematic by their genetic inheritance raises related questions. Should government, employers, health care providers, or others share the risks and accept the costs?

Reducing Health–Related Business Risks

In principle, relating to individuals—whether as customers or employees—carries risks as well as benefits for businesses. Ideally, risks can be revealed, assessed, and thereby reduced. But it has been hard to know in practice what the future holds in store for particular individuals. In practice, businesses with an interest in the future good health of employees or customers have adopted two approaches to reduce their risks.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading